Young adults with Down's syndrome show increased corticotrope responsiveness to hCRH or hexarelin, a peptidyl GH secretagogue

J Endocrinol Invest. 1999;22(10 Suppl):57-8.
No abstract available

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adrenocorticotropic Hormone / blood
  • Adult
  • Aged
  • Aged, 80 and over
  • Aging / blood
  • Aging / metabolism
  • Corticotropin-Releasing Hormone / pharmacology*
  • Down Syndrome / metabolism*
  • Down Syndrome / pathology
  • Humans
  • Hydrocortisone / blood
  • Middle Aged
  • Oligopeptides / pharmacology*
  • Pituitary Gland, Anterior / drug effects*
  • Pituitary Gland, Anterior / metabolism*
  • Pituitary Gland, Anterior / pathology

Substances

  • Oligopeptides
  • hexarelin
  • Adrenocorticotropic Hormone
  • Corticotropin-Releasing Hormone
  • Hydrocortisone